This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Kevin D. Lilly, VP, Marketing & Product Management, Standard Register Healthcare (Photo: Business Wire)

Standard Register Healthcare, a business unit of Standard Register (NYSE:SR), announced the appointment of Kevin D. Lilly as vice president of marketing and product management, continuing its transformation to a more agile, technology-driven, communications management business.

Kevin D. Lilly, VP, Marketing & Product Management, Standard Register Healthcare (Photo: Business Wi ...

Kevin D. Lilly, VP, Marketing & Product Management, Standard Register Healthcare (Photo: Business Wire)

A 26-year healthcare technology veteran, Lilly brings a broad base of experience in management, marketing and sales with large companies as well as start-ups. He began his career at Baxter Healthcare where he rose through the sales ranks to lead global sales and marketing for Baxter’s plasma business. Building on this early success, he assumed positions of increasing responsibility at Bell South, Facet Technologies and SpectRx before joining McKesson in 2005.

Over the last eight years, he held leadership roles at McKesson, advancing from vice president of Clinical/Physician Marketing to division vice president for Enterprise Visibility where he led efforts to merge the Visibility and Analytics teams, and create Relay Health’s Enterprise Intelligence organization, becoming vice president of sales.

Experienced in leading organizations through change and acquisition, Lilly has responsibility for Standard Register Healthcare’s $300 million portfolio of technology-enabled, clinical, marketing and operational products and services, which has become increasingly diverse with the acquisition of Dialog Medical in 2011 and WorkflowOne at the beginning of August.

“Kevin joins us at a strategic point in our transformation,” said John G. King, president of Standard Register Healthcare. “His leadership and experience will be invaluable as we align our organization to quickly develop and deploy the technology-enabled solutions that are so vital to helping healthcare providers collaborate and communicate with one another and their patients to improve the quality of care and outcomes.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,096.90 -106.47 -0.58%
S&P 500 2,098.53 -9.25 -0.44%
NASDAQ 4,967.1410 -12.76 -0.26%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs